Vanda Pharmaceuticals, Inc. VNDA was a big mover last session with its shares rising nearly 8% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This continues the recent downtrend of the company as the stock has lost over 10% since Nov 24.
This biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate has also remained unchanged. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Vanda Pharmaceuticals currently has a Zacks Rank #2 (Buy) and its Earnings ESP is 0.00%.
Investors interested in the biomed/gene space may also consider Heska Corp. HSKA, which sports a Zacks Rank #1 (Strong Buy).
Is VNDA going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment